Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a research study evaluating an investigational oral medication targeting cortisol-related metabolic dysfunction.
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a research study evaluating an investigational oral medication targeting cortisol-related metabolic dysfunction.
This research study is evaluating an investigational medication called clofutriben, which works by inhibiting an enzyme involved in cortisol regulation. By reducing the effects of excess cortisol, this therapy may help improve blood sugar control and overall metabolic health.
The purpose of this study is to better understand how well this medication works compared to placebo (inactive treatment), and to evaluate its safety in people with type 2 diabetes and elevated cortisol levels.
Qualifications
You may be able to join if you:
If you’re interested in participating or want to learn more, contact us today to see if you may qualify.
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a
Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in
Are you between 18 and 65 years old and being treated for depression? Even if your symptoms have improved, you
Suburban Research Associates is currently seeking participants 18 years or older who are struggling with generalized anxiety disorder for a
Suburban Research Associates in West Chester, PA is conducting a research study focused on Lyme disease prevention.
Suburban Research Associates is seeking adults living with Type 2 diabetes who have been diagnosed with diabetes-related kidney damage and